WO2024095209 - MINISTRING DNA FOR PRODUCING ADENO-ASSOCIATED VIRUS
National phase entry:
Publication Number
WO/2024/095209
Publication Date
10.05.2024
International Application No.
PCT/IB2023/061082
International Filing Date
02.11.2023
Title **
[English]
MINISTRING DNA FOR PRODUCING ADENO-ASSOCIATED VIRUS
[French]
ADN À MINI-CHAÎNE POUR LA PRODUCTION D'UN VIRUS ADÉNO-ASSOCIÉ
Applicants **
MEDIPHAGE BIOCEUTICALS, INC.
Inventors
SLAVCEV, Roderick
NAFISSI, Nafiseh
Priority Data
63/382,070
02.11.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4598 | |
| EPO | Filing, Examination, Granting | 53781 | |
| Japan | Filing, Examination, Granting | 3757 | |
| South Korea | Filing, Examination, Granting | 5416 | |
| USA | Filing, Examination, Granting | 25040 |
Total:
92,592
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Provided herein are expression vectors, vector production systems, bacterial sequence- free vectors, and methods for producing adeno-associated viruses (AAVs). Also provided are AAVs as well as pharmaceutical compositions and uses thereof.[French]
La présente invention concerne des vecteurs d'expression, des systèmes de production de vecteurs, des vecteurs bactériens sans séquence et des procédés de production de virus adéno-associés (AAV). La présente invention concerne également les AAV ainsi que les compositions pharmaceutiques et leurs utilisations.